Table 2

Bivariate analysis of symptoms/anamnesis

VariablesTBM
(n=85)
Non-TBM (n=82)P valueOR (95% CI min to max)
Prodromal duration ≥10 days, n (%)62 (72.9)22 (26.8)<0.0017.35 (3.71 to 14.57)
Systemic symptoms of TB, n (%)73 (85.9)21 (25.6)<0.00117.7 (8.05 to 38.8)
Vomiting, n (%)40 (47.1)34 (41.5)0.461.25 (0.68 to 2.231)
Cephalgia, n (%)34 (40)27 (32.9)0.340.72 (0.73 to 2.55)
Seizure, n (%)55 (64.7)67 (81.7)0.0130.41 (0.2 to 0.84)
Presence of TB contacts, n (%)32 (37.6)4 (4.9)<0.00111.77 (3.93 to 35.24)
No BCG vaccinated, n (%)26 (32.9)10 (12.7)0.0023.05 (1.45 to 6.38)
Immunocompromise, n (%)5 (5.9)2 (2.4)0.272.5 (0.47 to 13.26)
  • TB, tuberculosis; TBM, tuberculous meningitis.